NO20032215D0 - Laktamforbindelse - Google Patents
LaktamforbindelseInfo
- Publication number
- NO20032215D0 NO20032215D0 NO20032215A NO20032215A NO20032215D0 NO 20032215 D0 NO20032215 D0 NO 20032215D0 NO 20032215 A NO20032215 A NO 20032215A NO 20032215 A NO20032215 A NO 20032215A NO 20032215 D0 NO20032215 D0 NO 20032215D0
- Authority
- NO
- Norway
- Prior art keywords
- lactam compound
- lactam
- compound
- Prior art date
Links
- -1 lactam compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24965600P | 2000-11-17 | 2000-11-17 | |
PCT/US2001/027795 WO2002040451A2 (en) | 2000-11-17 | 2001-11-02 | Lactam compound |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20032215D0 true NO20032215D0 (no) | 2003-05-15 |
NO20032215L NO20032215L (no) | 2003-07-16 |
NO325217B1 NO325217B1 (no) | 2008-02-25 |
Family
ID=22944436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032215A NO325217B1 (no) | 2000-11-17 | 2003-05-15 | Laktamforbindelse, fremgangsmate for dets fremstilling samt farmasoytisk sammensetning inneholdende nevnte forbindelse |
Country Status (33)
Country | Link |
---|---|
US (1) | US20040248878A1 (no) |
EP (1) | EP1353910B1 (no) |
JP (1) | JP4116431B2 (no) |
KR (1) | KR20030045194A (no) |
CN (2) | CN101624372A (no) |
AR (1) | AR031356A1 (no) |
AT (1) | ATE362919T1 (no) |
AU (2) | AU2002224321B2 (no) |
BR (1) | BR0115424A (no) |
CA (1) | CA2425497C (no) |
CY (1) | CY1106682T1 (no) |
CZ (1) | CZ20031340A3 (no) |
DE (1) | DE60128587T2 (no) |
DK (1) | DK1353910T3 (no) |
DZ (1) | DZ3454A1 (no) |
EA (1) | EA006919B1 (no) |
EC (1) | ECSP034598A (no) |
ES (1) | ES2286162T3 (no) |
HR (1) | HRP20030385A2 (no) |
HU (1) | HUP0301862A3 (no) |
IL (1) | IL155275A0 (no) |
MX (1) | MXPA03004250A (no) |
MY (1) | MY141607A (no) |
NO (1) | NO325217B1 (no) |
PE (1) | PE20020798A1 (no) |
PL (1) | PL211018B1 (no) |
PT (1) | PT1353910E (no) |
SK (1) | SK287794B6 (no) |
SV (1) | SV2003000741A (no) |
TW (1) | TWI235151B (no) |
UA (1) | UA77165C2 (no) |
WO (1) | WO2002040451A2 (no) |
ZA (1) | ZA200303411B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74849C2 (en) * | 2000-11-17 | 2006-02-15 | Lilly Co Eli | Lactam |
RU2423353C1 (ru) | 2002-12-20 | 2011-07-10 | Глэксо Груп Лимитед | Новые производные бензазепина |
US8293751B2 (en) | 2003-01-14 | 2012-10-23 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
JP5039543B2 (ja) | 2005-04-08 | 2012-10-03 | 第一三共株式会社 | ピリジルメチルスルホン誘導体 |
WO2007088878A1 (ja) | 2006-01-31 | 2007-08-09 | Api Corporation | ベンゾアゼピノン類の製造方法 |
TW200920362A (en) | 2007-09-11 | 2009-05-16 | Daiichi Sankyo Co Ltd | Alkylsulfone derivatives |
FR2932800B1 (fr) * | 2008-06-20 | 2015-02-20 | Servier Lab | Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
KR101899014B1 (ko) | 2012-01-06 | 2018-09-17 | 삼성전자주식회사 | 비엘디씨 모터의 제어 장치 및 그 방법 |
CN102690231B (zh) * | 2012-04-11 | 2014-07-09 | 南京友杰医药科技有限公司 | 治疗阿尔茨海默病潜在药物司马西特的合成方法 |
US20160067306A1 (en) | 2013-04-19 | 2016-03-10 | National University Corporation Hokkaido University | Treatment agent for cognitive impairment induced by amyloid beta-protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these |
UA126268C2 (uk) | 2015-01-06 | 2022-09-14 | Арена Фармасьютікалз, Інк. | СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub> |
EA201890096A1 (ru) | 2015-06-22 | 2018-08-31 | Арена Фармасьютикалз, Инк. | КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ |
US11534424B2 (en) | 2017-02-16 | 2022-12-27 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
US20230118517A1 (en) | 2020-03-26 | 2023-04-20 | Seagen Inc. | Methods of treating multiple myeloma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3812952B2 (ja) * | 1996-12-23 | 2006-08-23 | エラン ファーマシューティカルズ,インコーポレイテッド | シクロアルキル、ラクタム、ラクトンおよびその関連化合物およびその医薬組成物、並びに該化合物を用いたβ−アミロイドペプチドの放出および/またはその合成を阻害する方法 |
JP2002518481A (ja) * | 1998-06-22 | 2002-06-25 | エラン ファーマシューティカルズ,インコーポレイテッド | β−アミロイドペプチドの放出および/またはその合成を阻害するための化合物 |
CA2390376A1 (en) * | 1999-11-09 | 2001-05-17 | William Leonard Scott | .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis |
-
2001
- 2001-02-11 UA UA2003054406A patent/UA77165C2/uk unknown
- 2001-11-02 HU HU0301862A patent/HUP0301862A3/hu unknown
- 2001-11-02 IL IL15527501A patent/IL155275A0/xx unknown
- 2001-11-02 WO PCT/US2001/027795 patent/WO2002040451A2/en active IP Right Grant
- 2001-11-02 CZ CZ20031340A patent/CZ20031340A3/cs unknown
- 2001-11-02 MX MXPA03004250A patent/MXPA03004250A/es active IP Right Grant
- 2001-11-02 JP JP2002542779A patent/JP4116431B2/ja not_active Expired - Fee Related
- 2001-11-02 DE DE60128587T patent/DE60128587T2/de not_active Expired - Lifetime
- 2001-11-02 AU AU2002224321A patent/AU2002224321B2/en not_active Ceased
- 2001-11-02 DZ DZ013454A patent/DZ3454A1/fr active
- 2001-11-02 AU AU2432102A patent/AU2432102A/xx active Pending
- 2001-11-02 SK SK543-2003A patent/SK287794B6/sk not_active IP Right Cessation
- 2001-11-02 DK DK01996530T patent/DK1353910T3/da active
- 2001-11-02 US US10/415,548 patent/US20040248878A1/en not_active Abandoned
- 2001-11-02 EA EA200300579A patent/EA006919B1/ru unknown
- 2001-11-02 AT AT01996530T patent/ATE362919T1/de active
- 2001-11-02 PL PL360991A patent/PL211018B1/pl unknown
- 2001-11-02 CA CA2425497A patent/CA2425497C/en not_active Expired - Fee Related
- 2001-11-02 PT PT01996530T patent/PT1353910E/pt unknown
- 2001-11-02 CN CN200910203885A patent/CN101624372A/zh active Pending
- 2001-11-02 CN CNB018189962A patent/CN100516047C/zh not_active Expired - Fee Related
- 2001-11-02 KR KR10-2003-7006660A patent/KR20030045194A/ko not_active Application Discontinuation
- 2001-11-02 ES ES01996530T patent/ES2286162T3/es not_active Expired - Lifetime
- 2001-11-02 BR BR0115424-9A patent/BR0115424A/pt not_active Application Discontinuation
- 2001-11-02 EP EP01996530A patent/EP1353910B1/en not_active Expired - Lifetime
- 2001-11-15 AR ARP010105339A patent/AR031356A1/es not_active Application Discontinuation
- 2001-11-15 MY MYPI20015251A patent/MY141607A/en unknown
- 2001-11-15 TW TW090128351A patent/TWI235151B/zh not_active IP Right Cessation
- 2001-11-16 PE PE2001001143A patent/PE20020798A1/es not_active Application Discontinuation
- 2001-11-16 SV SV2001000741A patent/SV2003000741A/es unknown
-
2003
- 2003-05-02 ZA ZA200303411A patent/ZA200303411B/en unknown
- 2003-05-13 EC EC2003004598A patent/ECSP034598A/es unknown
- 2003-05-14 HR HR20030385A patent/HRP20030385A2/hr not_active Application Discontinuation
- 2003-05-15 NO NO20032215A patent/NO325217B1/no unknown
-
2007
- 2007-06-28 CY CY20071100848T patent/CY1106682T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20032236D0 (no) | Laktamforbindelse | |
NO20026196L (no) | Kinazolinditosylatsalt-forbindelser | |
DK1619192T3 (da) | Arylkondeserede azapolycykliske forbindelser | |
DK1226127T3 (da) | Substituerede phenylsulfamoylcarboxamider | |
DK1255740T3 (da) | Substituerede arylpyraziner | |
AR028393A1 (es) | Iminoazidas substituidas | |
NO20032215L (no) | Laktamforbindelse | |
PT1268453E (pt) | Metabolitos de agonista/antagonista de estrogenio | |
DE50112662D1 (de) | Substituierte benzoylcyclohexenone | |
AR028302A1 (es) | Feniluracilos substituidos | |
ID29755A (id) | Senyawa-senyawa organosilikon | |
IT250181Y1 (it) | Custodia perfezionata per rivoltella | |
ATE372338T1 (de) | Deshalogenverbindungen | |
NO20030303D0 (no) | Kalsilytiske forbindelser | |
NO20023508L (no) | Kalsilyttiske forbindelser | |
NO20031837D0 (no) | Kalsilytiske forbindelser | |
TR200100070A3 (tr) | Bilesim | |
MX231963B (es) | Poliamidas | |
SE0003477D0 (sv) | Compounds | |
SE0004680D0 (sv) | New compound | |
SE0002234D0 (sv) | Novel compounds | |
SE0003437D0 (sv) | Novel compounds | |
SE0003979D0 (sv) | Novel Compounds | |
SE0003436D0 (sv) | Novel compounds | |
SE0003203D0 (sv) | Novel compounds |